Bank of Montreal’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bank of Montreal’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7,864	Closed	-$339K	–	4632
2015 Q3	$339K	Sell	7,864 -4,109	-34%	-$173K	﹤0.01%	2038
2015 Q2	$506K	Sell	11,973 -7,002	-37%	-$295K	﹤0.01%	1970
2015 Q1	$736K	Sell	18,975 -12,223	-39%	-$471K	﹤0.01%	1766
2014 Q4	$1.05M	Sell	31,198 -28,448	-48%	-$1M	﹤0.01%	1695
2014 Q3	$2.09M	Buy	59,646 +2,231	+4%	+$76.5K	﹤0.01%	1453
2014 Q2	$1.89M	Sell	57,415 -1,242	-2%	-$42.5K	﹤0.01%	1483
2014 Q1	$2.16M	Sell	58,657 -13,651	-19%	-$501K	﹤0.01%	1298
2013 Q4	$2.78M	Buy	72,308 +33,738	+87%	+$1.07M	﹤0.01%	1044
2013 Q3	$1.06M	Buy	38,570 +30,134	+357%	+$714K	﹤0.01%	1426
2013 Q2	$177K	Buy	+8,436	New	+$165K	﹤0.01%	2248

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Bank of Montreal's WX Position: Q4 2015 in Review

Bank of Montreal sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 7,864 shares — an estimated $339K sold.

Bank of Montreal first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $2.78M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Bank of Montreal reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Bank of Montreal sold 7,864 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $339K.
Bank of Montreal first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
Bank of Montreal's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $2.78M in Q4 2013.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Bank of Montreal's 13F filing for Q4 2015, filed 9 Feb 2016.